Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-02-01 @ 7:23 AM
Study NCT ID:
NCT04231292
Status:
UNKNOWN
Last Update Posted:
2020-01-18
First Post:
2020-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
Sponsor:
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SZSBE-RD01-HD-II-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None